Fluoroscopy Equipment Market Growing Demand for Data Integrated Imaging Systems Will Offer Significant Opportunities

Luton, Bedfordshire, United Kingdom, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the  Fluoroscopy Equipment market.

The global fluoroscopy equipment market is expected to grow at a 3.88% CAGR from 2020 to 2029. It is expected to reach above USD 7.24 billion by 2029 from USD 5.14 billion in 2020.

Fluoroscopy equipment is routinely utilized in a wide range of interventional radiological treatments, particularly in the treatment of varicose veins, Peripheral Artery Disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other common medical problems. This regular usage is expected to boost the market for fluoroscopy equipment in the forecast period. Furthermore, an increasing number of orthopedic operations and angiography as a result of sports injuries, as well as a growing senior population base, are likely to be high impact rendering drivers. Because of its ability to perform effective real-time injury evaluation in athletes, hand-held fluoroscopes are gaining favor in emergency rooms and on-site situations. The use of fluoroscopes in sports medicine is also expected to increase as a consequence of associated benefits such as low cost and mobility.

Promoting efficient treatment facilities served as key contributing growth factor in the fluoroscopy equipment market. A growing number of government efforts targeted at supporting efficient treatment facilities in order to create speedy outcomes and increase overall healthcare efficiency also had a role in growth. For example, a U.S. FDA push to limit and optimize radiation exposure in medical imaging has resulted in improved treatment of many disorders and increased hospital safety. These reasons are responsible for hospitals gaining a bigger proportion of the end-use segment.

Download Report (100 Pages PDF with Insights, Charts, Tables, Figures) at:

 https://exactitudeconsultancy.com/reports/7295/fluoroscopy-equipment-market/#request-a-sample

In 2019 Siemens Healthineers (Germany) introduced the Artis icono biplane, an angiography system with neuroradiology-specific functionality.

In 2019, The Zenition mobile C-arm platform was introduced by Philips (Netherlands).

Product Portfolio: The Company has a product portfolio of Fluoroscopy Equipment Market that includes:

Fluoroscopy Equipment Market: Growing competition among key players, increasing horizontal and vertical expansion is further expected to fuel the growth of Fluoroscopy Equipment Market.

Key players operating the global Siemens Healthineers ,GE Healthcare ,Philips ,Shimadzu Corporation ,Ziehm Imaging ,Canon Medical Systems ,Hitachi ,Carestream Health ,Hologic ,Lepu Medical Technology ,Agfa-Gevaert Group ,ADANI Systems ,GENORAY ,Medtronic ,OrthoScan ,Allengers Medical Systems ,STEPHANIX ,MS Westfalia ,ITALRAY ,Eurocolumb ,Omega Medical Imaging ,LISTEM Corporation ,Xcelsitas AG ,General Medical Merate ,SternMed.

Fluoroscopy Equipment Market Scope: Discount on report

Report Coverage of Fluoroscopy Equipment Market

Browse Detailed Research Insights with TOC:

https://exactitudeconsultancy.com/reports/7295/fluoroscopy-equipment-market  Regional Dominance: Its major share is occupied by North America, Europe, Middle East & Africa (MEA), and Asia Pacific. North America shares 34% of the total market.

North America held the highest share of the fluoroscopy equipment market in 2019. Factors such as the rising frequency of overuse sports injuries, the rising prevalence of CVD, and the increasing number of hip and knee replacement operations are propelling the North American fluoroscopy equipment market ahead.

Click here to avail lucrative discounts on our latest report:

https://exactitudeconsultancy.com/reports/7295/fluoroscopy-equipment-market/#inquire-for-discount

Explore Trending Healthcare Industry Research Reports:

The global healthcare middleware market is expected to grow at 11% CAGR from 2022 to 2029. It is expected to reach above USD 5.65 billion by 2029 from USD 2.21 billion in 2020.

The global Healthcare/Medical Simulation Market is expected to grow at 15.0% CAGR from 2022 to 2029. It is expected to reach above USD 5.28 billion by 2029 from USD 1.5 billion in 2020.

Cancer biomarkers market size was valued at USD 11.38 billion in 2020 and is projected to reach USD 48.58 billion by 2029, growing at a CAGR of 17.5% from 2022 to 2029.

The global hepatitis testing/diagnosis market is expected to grow at a 5 % CAGR from 2022 to 2029. It is expected to reach above USD 4.14 billion by 2029 from USD 2.66 billion in 2020.

The global Orthodontic Supplies market size is USD 4.95 billion in 2020 and is expected to grow till USD 11.66 billion by 2029, at a Compounded annual growth rate (CAGR) of 10.20%.

Mizuho analyst Vijay Rakesh just lowered his price target on Nvidia, but if he's right it's a good buy from here.

In this article, we will take a look at the 10 Blue Chip Stocks to Buy Now According to Billionaire George Soros. To skip our analysis of George Soros’ profile, investment strategy, and 13F holdings, you can go directly to see the 5 Blue Chip Stocks to Buy Now According to Billionaire George Soros. George […]

Struggling Bed Bath & Beyond Inc. releases a list of dozens of stores it aims to close. Most of the stores on this list will close by the end of the month.

Amazon's founder and executive chairman was the world's richest man for several years before falling to second place.

Yahoo Finance Live anchors discuss stock performance for FedEx.

FedEx has blown three tires before the peak holiday shipping season, and chatter on the Street is that mighty Amazon may have played a role.

Long-time Real Money subscribers have come to learn I like to combine investment approaches. No one investment approach (fundamental, technical, quantitative) is perfect and better results can come from blending or combining different methods. The On-Balance-Volume (OBV) line has also moved sideways suggesting a balance between buyers and sellers.

Central banks are like “reformed smokers,” famed investor Stanley Druckenmiller says. “They’ve gone from printing a bunch of money, like driving a Porsche at 200 miles an hour, to not only taking the foot off the gas, but just slamming the brakes on.”

NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.

There was a sell-off in cardboard packaging stocks this morning, with shares of International Paper (NYSE: IP) down 9.4% at 10:30 a.m. ET on Friday, Packaging Corporation of America (NYSE: PKG) shares down 9.7%, and the stock of WestRock (NYSE: WRK) down 9.8%. Shares of FedEx (NYSE: FDX) plunged more than 22% this morning after the company issued an earnings warning predicated on softening global volume. The volume FedEx referred to was the number of packages wrapped in cardboard and shipped to customers.

Yahoo Finance's Ines Ferré breaks down how stocks are moving near the close of the week, consumer sentiment, and ExxonMobil's market cap nearing that of Meta.

After three months of highly volatile trading, which have seen the S&P 500 drop down toward 3,600, rally up to 4,300, and fall back down to 3,900, investors can be forgiven for feeling some whiplash. The question that needs answering, however, is where will the markets go from here? Morgan Stanley strategist Andrew Slimmon believes that investors shouldn’t worry too much about the bear case. Worse-than-expected inflation numbers for August may have pushed the markets into a tumble this week, but

Wall Street is on a roller coaster again, as investors try to navigate the path between high inflation and the Fed’s aggressive interest rate hikes. What we know for certain is that the S&P 500 is down 18% year-to-date, and the NASDAQ is down 26%. At least one investing expert, however, is getting on his soapbox to encourage investors to buy now, while prices are low. This is the view of Shark Tank investor Kevin O’Leary. The venture capitalist makes a case for investors to take advantage of vol

As bad the news was for FedEx, it may be worse news for the U.S. economy --- and an early sign of a recession.

You can't guess the bottom. But a bargain is a bargain.

Alibaba Group Holding Limited stock is trending on the Yahoo Finance Platform. Here is a visualization of $BABA performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.

There was no good news in the August inflation numbers. While the annualized rate did fall slightly from July, from 8.5% to 8.3%, it came in higher than expected – and worse, the core CPI rate, rather than dropping, increased to 6.3%. Consumers are struggling, and their pain is real. But it’s not only consumers who are getting hit hard by inflation. Retailers are also feeling the strain, and they’re feeling it twice – from consumers, whose wallets are pinched and so are buying less, and from the

It's no secret that investors are worried about runaway inflation. Cathie Wood and Elon Musk see deflation as the bigger threat.

FedEx turned in poor earnings results and slashed its revenue forecast on Thursday as the company’s CEO warned that a “worldwide recession” is likely coming.

Argus Director of Portfolio Strategy John Eade joins Yahoo Finance Live to discuss FedEx's dire profit warning and how it affects the CEO's reputation as chief executive.